VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $155 | -11.9% | 25,990 | 0.0% | 0.01% | -7.1% |
| Q1 2023 | $176 | -8.3% | 25,990 | 0.0% | 0.01% | -17.6% |
| Q4 2022 | $192 | -99.8% | 25,990 | +138.7% | 0.02% | +70.0% |
| Q3 2022 | $108,000 | -9.2% | 10,890 | 0.0% | 0.01% | -9.1% |
| Q2 2022 | $119,000 | -3.3% | 10,890 | 0.0% | 0.01% | +22.2% |
| Q1 2022 | $123,000 | -28.1% | 10,890 | 0.0% | 0.01% | -30.8% |
| Q4 2021 | $171,000 | -8.6% | 10,890 | 0.0% | 0.01% | -13.3% |
| Q3 2021 | $187,000 | -20.1% | 10,890 | 0.0% | 0.02% | -21.1% |
| Q2 2021 | $234,000 | +42.7% | 10,890 | 0.0% | 0.02% | +26.7% |
| Q1 2021 | $164,000 | +14.7% | 10,890 | 0.0% | 0.02% | +7.1% |
| Q4 2020 | $143,000 | +36.2% | 10,890 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $105,000 | -18.0% | 10,890 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $128,000 | +13.3% | 10,890 | 0.0% | 0.02% | -6.2% |
| Q1 2020 | $113,000 | – | 10,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |